Commentary: Don’t let Adderall scarcity trigger a repeat of the opioid epidemic
by Leo Beletsky, Los Angeles Times
Nov 15, 2022
2 minutes
U.S. pharmacies are critically low on Adderall and its generic equivalents, leaving more than 26 million patients scrambling and competing for the pills since late summer. The scarcity is going to last for many more months because of supply chain problems as well as federal restrictions on manufacturers and imports.
If we don’t act fast, this shortage could trigger two major public health crises.
Many people who have been taking
You’re reading a preview, subscribe to read more.
Start your free 30 days